Summit Trail Advisors’s Cavium, Inc. CAVM Stock Holding History

Summit Trail Advisors’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-47	Closed	-$4K	–	2133
2017 Q4	$4K	Buy	+47	New	+$3.64K	﹤0.01%	1516

Other funds holding CAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Summit Trail Advisors's CAVM Position: Q1 2018 in Review

Summit Trail Advisors sold out of Cavium, Inc. (CAVM) in Q1 2018, closing a stake of 47 shares — an estimated $4K sold.

Summit Trail Advisors first reported a position in CAVM in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 256 funds tracked by Wall St. Rank hold CAVM as of Q1 2018.

Summit Trail Advisors reported no remaining Cavium, Inc. position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 47 Cavium, Inc. shares in Q1 2018, an estimated $4K.
Summit Trail Advisors first reported a position in Cavium, Inc. in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Cavium, Inc. position peaked at $4K in Q4 2017.
256 funds tracked by Wall St. Rank held Cavium, Inc. as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.